SCHEMBL7701060

SCHEMBL7701060

CCCCc1nc(SC)c(OC(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCCC)cc1

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 7/20 0.80
AGTR1 P30556 4/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021275 0.95 AGTR2 (0.79) AGTR2AGTR1
SCHEMBL7022995 0.93 AGTR2 (0.70) AGTR2AGTR1
SCHEMBL7706786 0.92 AGTR2 (0.75) AGTR2AGTR1
SCHEMBL8555681 0.91 AGTR2 (0.68) AGTR2AGTR1
SCHEMBL6544948 0.89 AGTR2 (0.79) AGTR2AGTR1
SCHEMBL7701057 0.89 AGTR2 (1.00) AGTR2AGTR1
SCHEMBL8976602 0.89 AGTR2 (1.00) AGTR2AGTR1
SCHEMBL8976768 0.88 AGTR2 (0.98) AGTR2AGTR1
Potassium SCHEMBL8976441 0.88 AGTR2 (0.98) AGTR2AGTR1
SCHEMBL7706134 0.88 AGTR2 (0.81) AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0644188-B1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained AVENTIS PHARMA SA (FR) 2002-12-04 EP claimed
EP-0577023-A2 Angiotensin-II receptor-antagonists for the treatment of arrhythmices HOECHST AKTIENGESELLSCHAFT (DE) 1994-01-05 EP disclosed
EP-0577025-A2 Angiotensin-II-receptorantagonist for the treatment and prophylaxis of coronary heart diseases HOECHST AKTIENGESELLSCHAFT (DE) 1994-01-05 EP disclosed